levofloxacin has been researched along with prednisone in 24 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (prednisone) | Trials (prednisone) | Recent Studies (post-2010) (prednisone) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 41,222 | 5,274 | 8,409 |
| Protein | Taxonomy | levofloxacin (IC50) | prednisone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 1.146 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.146 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 13 (54.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dobie, D; Hastings, M; Mahendra, P; Richardson, G; Tauro, S | 1 |
| De Simone, C; Famularo, G | 1 |
| Cervera, R; de La Red, G; Font, J; Lladó, A; Mejía, JC; Mensa, J | 1 |
| Farney, AC; Mendley, SR; Mian, AN | 1 |
| Hou, Y; Lü, C; Wu, ZP; Xiao, N; Yang, MG; Zhao, XK | 1 |
| Butler, NJ; Suhler, EB | 1 |
| Aaron, SD; Bourbeau, J; Field, SK; FitzGerald, JM; Mallick, R; Maltais, F; Marciniuk, DD; Nair, P; Sin, DD; Vandemheen, KL | 1 |
| Chen, JH; Lin, ZQ; Wang, TT | 1 |
| Bruguera, M; Forns, X; García Juárez, I; Miquel, R | 1 |
| Chen, YP; Cheng, H; Wang, GQ; Xu, XY | 1 |
| Armesto, A; Calviño, J; Cigarrán, S; Coronel, D | 1 |
| Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW | 1 |
| Chinen, S; Ishizu, M; Mogi, A; Nakashima, Y; Sasaki, H; Takamatsu, Y; Takata, T; Tanaka, T | 1 |
1 review(s) available for levofloxacin and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for levofloxacin and prednisone
| Article | Year |
|---|---|
[Corticoid combined with an antibiotic for chronic nonbacterial prostatitis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Glucocorticoids; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prednisone; Prostatitis; Treatment Outcome; Young Adult | 2009 |
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Double-Blind Method; Etanercept; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Immunoglobulin G; Levofloxacin; Male; Middle Aged; Ofloxacin; Prednisone; Pulmonary Disease, Chronic Obstructive; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
21 other study(ies) available for levofloxacin and prednisone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carmustine; Cefotaxime; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Idarubicin; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Lymphoma, T-Cell; Male; Melphalan; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Prednisone; Recurrence; Rifampin; Splenectomy; Streptococcus pneumoniae; Transplantation Conditioning; Vincristine | 2000 |
Nephrotoxicity and purpura associated with levofloxacin.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Diuretics; Drug Eruptions; Furosemide; Humans; Kidney Function Tests; Levofloxacin; Liver Function Tests; Lung Neoplasms; Male; Myeloproliferative Disorders; Ofloxacin; Prednisone; Purpura | 2002 |
Bilateral Achilles tendinitis with spontaneous rupture induced by levofloxacin in a patient with systemic sclerosis.
Topics: Achilles Tendon; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prednisone; Risk Assessment; Rupture, Spontaneous; Scleroderma, Systemic; Severity of Illness Index; Tendinopathy | 2003 |
Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature.
Topics: Adolescent; Arthritis, Infectious; Doxycycline; Edema; Female; Graft Survival; Hip; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Levofloxacin; Magnetic Resonance Imaging; Mycophenolic Acid; Mycoplasma hominis; Ofloxacin; Pelvis; Prednisone; Radiography; Tacrolimus; Treatment Outcome | 2005 |
Levofloxacin-associated panuveitis with chorioretinal lesions.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Bites and Stings; Female; Fluorescein Angiography; Glucocorticoids; Humans; Levofloxacin; Ofloxacin; Panuveitis; Prednisone; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity | 2012 |
Successful application of a novel dressing for the treatment of ulcerative cutaneous sarcoidosis.
Topics: Ascorbic Acid; Bandages; Calcium Gluconate; Humans; Levofloxacin; Male; Middle Aged; Prednisone; Sarcoidosis; Skin Ulcer | 2013 |
[Levofloxacin-induced autoimmune hepatitis. Description of a case].
Topics: Adrenal Cortex Hormones; Alanine Transaminase; Anti-Asthmatic Agents; Aspartate Aminotransferases; Asthma; Biopsy; Chemical and Drug Induced Liver Injury; Eosinophilia; Female; Hepatitis, Autoimmune; Humans; Levofloxacin; Liver; Middle Aged; Nasal Polyps; Prednisone; Recurrence; Respiratory Tract Infections | 2014 |
Renal Parenchymal Malakoplakia Presenting as Acute Renal Failure in a Young Woman.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cyclophosphamide; Female; Humans; Kidney Diseases; Levofloxacin; Malacoplakia; Prednisone | 2016 |
Legionella Pneumophila: A Renal Vasculitis Trigger?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cyclophosphamide; Humans; Immunosuppressive Agents; Kidney Diseases; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Prednisone; Renal Dialysis; Vasculitis | 2016 |
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole | 2017 |
Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fever; Humans; Levofloxacin; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Vincristine; Young Adult | 2020 |